Treatment horizon in multiple myeloma.

导出 LinkOut

翻译打印收藏纠错

作者： Cinnie Yentia,Soekojo ^[1] ; Wee Joo,Chng ^[2]

作者单位： Department of Hematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore. ^[1] Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. ^[2] N2CR and Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. ^[3]

关键词 ADC BiTE CAR-T celmod immunotherapy melflufen monoclonal antibody multiple myeloma selinexor venetoclax

主题词抗体, 单克隆(Antibodies, Monoclonal);人类(Humans);免疫轭合物(Immunoconjugates);免疫疗法(Immunotherapy);免疫疗法, 过继(Immunotherapy, Adoptive);多发性骨髓瘤(Multiple Myeloma)

DOI 10.1111/ejh.13840

PMID 35880395

发布时间 2022-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交